John Tilton

Insider Reports History

Location
C/O Biohaven Pharmaceutical Holding Comp, 234 Church Street, New Haven, CT
Signature
/s/ George Clark, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Tilton:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Biohaven Pharmaceutical Holding Co Ltd. Chief Commercial Officer Common Shares 1.61K Oct 3, 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Commercial Officer Common Shares 0 Oct 3, 2022 By JET Ventures LLC
Biohaven Pharmaceutical Holding Co Ltd. Chief Commercial Officer Restricted Share Unit Award 0 Oct 3, 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Commercial Officer Stock Options (Right to Buy) 0 Oct 3, 2022 Direct

Insider Reports Filed by John Tilton

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BHVN Biohaven Pharmaceutical Holding Co Ltd. Oct 3, 2022 16 -$992K 4 Oct 3, 2022 Chief Commercial Officer
BHVN Biohaven Pharmaceutical Holding Co Ltd. Jan 6, 2022 8 -$112K 4 Jan 7, 2022 Chief Commercial Officer
BHVN Biohaven Pharmaceutical Holding Co Ltd. Nov 25, 2021 3 -$56.9K 4 Nov 26, 2021 Chief Commercial Officer